These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 2110560

  • 1. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS, Kobak KA, Jefferson JW, Mazza J, Greist JH.
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [Abstract] [Full Text] [Related]

  • 2. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM.
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [Abstract] [Full Text] [Related]

  • 3. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W, Wilson WH, Ban TA, King DL, Manov G, Fjetland OK.
    Psychopharmacol Bull; 1984 Mar; 20(1):73-8. PubMed ID: 6425916
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of major affective disorder with fluvoxamine.
    Lapierre YD, Browne M, Horn E, Oyewumi LK, Sarantidis D, Roberts N, Badoe K, Tessier P.
    J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
    [Abstract] [Full Text] [Related]

  • 5. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.
    Lydiard RB, Laird LK, Morton WA, Steele TE, Kellner C, Laraia MT, Ballenger JC.
    Psychopharmacol Bull; 1989 Feb; 25(1):68-70. PubMed ID: 2505304
    [No Abstract] [Full Text] [Related]

  • 6. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP, Boyer WF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [Abstract] [Full Text] [Related]

  • 7. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [Abstract] [Full Text] [Related]

  • 8. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E, Feighner J, Mandos LA, Rickels K.
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [Abstract] [Full Text] [Related]

  • 9. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K, Wykoff W, Tynes LL, Schneider L, Zemansky M.
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [Abstract] [Full Text] [Related]

  • 10. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F, Swinkels J, Tuynman-Qua H.
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [Abstract] [Full Text] [Related]

  • 11. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB, Wilcox CS.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [Abstract] [Full Text] [Related]

  • 12. Nefazodone: aspects of efficacy.
    Rickels K, Robinson DS, Schweizer E, Marcus RN, Roberts DL.
    J Clin Psychiatry; 1995 Feb; 56 Suppl 6():43-6. PubMed ID: 7649973
    [Abstract] [Full Text] [Related]

  • 13. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.
    Psychopharmacol Bull; 1990 Feb; 26(2):185-9. PubMed ID: 2146697
    [Abstract] [Full Text] [Related]

  • 14. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB, Varga L, Lyford A.
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [Abstract] [Full Text] [Related]

  • 15. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK, Shrivastava SH, Overweg N, Blumhardt CL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [Abstract] [Full Text] [Related]

  • 16. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM, Shrivastava RK, Mukherjee S, Coleman BS, Michael ST.
    Br J Clin Pharmacol; 1983 Feb; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [Abstract] [Full Text] [Related]

  • 17. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD, Dreyfus JF, Pichot P.
    Br J Clin Pharmacol; 1983 Feb; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [Abstract] [Full Text] [Related]

  • 18. Fluvoxamine and imipramine: results of a long-term controlled trial.
    Guelfi JD, Dreyfus JF, Pichot P.
    Int Clin Psychopharmacol; 1987 Apr; 2(2):103-9. PubMed ID: 3110264
    [Abstract] [Full Text] [Related]

  • 19. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
    Norton KR, Sireling LI, Bhat AV, Rao B, Paykel ES.
    J Affect Disord; 1984 Dec; 7(3-4):297-308. PubMed ID: 6241211
    [Abstract] [Full Text] [Related]

  • 20. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
    Claghorn JL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.